Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001178913-17-001170

Chief Scientific Officer sold 52,814 shares at $6.33 ($334,313)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kidron Miriam Chief Scientific Officer 2017-04-19 Sale −52,814 $6.33 $334,313 89,636 D: show line 1 in the form
Open-market sales · 52,814 sh · avg $6.33 · $334,313
Loading xslF345X03/zk1719828.xml…